Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Intraosseous Infusion Devices market size was valued at USD 431.7 Million in 2022 and will reach USD 705.34 Million in 2028, with a CAGR of 8.53% during 2022-2028.
Intraosseous Infusion Devices are medical devices that help infuse drugs, fluids or blood products directly into the bone marrow, for emergency situations. Intraosseous Infusion Devices offer the fastest way to quickly infuse needed medications and fluids in emergency situations.
Market Drivers Analysis
Application of Intraosseous Infusion Devices in First Aid
In the emergency process, the establishment of a fast and effective infusion channel is the prerequisite for ensuring emergency medication. The key to successful rescue is to quickly establish infusion channels for critically ill patients in the emergency department and to quickly infuse fluids with medication. However, unforeseen problems are often encountered during first aid, such as: peripheral circulatory failure in a state of shock, venous collapse, or patient agitation that does not cooperate with the operation; ambulance bumps on the way, making the operation difficult; the scene is complicated and dangerous, or other conditions are limited etc., often delay the rescue time because of the inability to quickly establish an intravenous infusion channel. Bone marrow infusion is easy to identify because of the bone landmarks, and it can be operated in various postures and poor environmental conditions, with a high success rate. For example, emergency surgical critical illness is more common in the emergency department. Taking traffic accidents as an example, the wounded may have craniocerebral injury and chest and abdominal injury at the same time. Complex and critical injuries are often accompanied by shock. Infusion is an important means of anti-shock treatment, but the environment of venipuncture Strict requirements, high requirements for puncture technology, in some special patients such as severe burns, car accidents, explosion wounded, obese patients with edema, shock patients with poor vascular filling, critical patients with sudden cardiac arrest, etc. When there is no available blood vessel, it is difficult to quickly establish a reliable fluid pathway, leaving the healer in a dilemma. In this case, Intraosseous Infusion Devices are the best way to help establish emergency infusion access. In general, the application of Intraosseous Infusion Devices in emergency treatment is one of the driving factors driving the development of the industry.
Challenges Analysis
The popularity of Intraosseous Infusion Devices in some areas is not high
At present, in some areas, the intraosseous cavity infusion technology is still backward, and medical staff do not fully understand the technology and devices. For example, medical staff hold a wait-and-see attitude towards intraosseous infusion technology. The cognition of medical staff on infusion is still at the stage of intravenous administration, and it is difficult to accept the method of intraosseous infusion, and they are worried about the occurrence of complications after infusion, which makes the clinical implementation of intraosseous infusion not smooth. In addition, in terms of medical education, medical students have not learned the knowledge of intraosseous infusion during school, and most hospitals have no relevant training on intraosseous infusion. Still skeptical about the effect of intraosseous infusion, not even using the concept of Intraosseous Infusion Devices. These reasons lead to the low penetration rate of Intraosseous Infusion Devices in critically ill patients, less clinical use, and slower development. In most areas, the original manual bone puncture needle is used for bone puncture. Generally speaking, the low popularity of Intraosseous Infusion Devices in some areas is one of the important factors restricting the development of the industry.
Region Overview:
In 2022, the share of the Intraosseous Infusion Devices market in United States stood at 50.19% .
Company Overview:
Teleflex is a global medical technology provider that improves people's health and quality of life. The company's diverse product portfolio offers solutions in the areas of vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care. The company's brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®, among others. 2020, Teleflex Incorporated has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases.
BD is one of the world's largest global medical technology companies, advancing a healthy world by improving medical discovery, diagnosis and care delivery. The company supports healthcare frontline heroes by developing innovative technologies, services and solutions that help advance clinical care for patients and clinical processes for healthcare providers. On June 22, 2022, BD announced a voluntary recall of the BD™ Intraosseous Needle Set, BD™ Intraosseous Manual Driver Set and BD™ Intraosseous Power Driver.
Teleflex is one of the major players operating in the Intraosseous Infusion Devices market, holding a share of 54.56% in 2023.
Segmentation Overview:
Manual
Differentiate according to the driving mode. Manual devices require the provider to twist the device by hand to pierce the skin, tissue, and bone for access to the bone marrow.
Automatic
Automatic devices include semi-automatic and automatic. This type of product is easy to operate and easy to puncture. Some products of this type are powered by batteries, and common brands on the market include FAST, BIG, etc.
By type, Manual segment accounted for the largest share of market in 2022.
Application Overview:
Mainly divide Hospitals and Ambulatory Surgical Centers according to different downstream institutions. In contrast to Hospitals, Ambulatory Surgical Centers focuses on providing same-day surgical care, including diagnostic and preventive procedures. Ambulatory surgery centers provide surgery without an overnight stay. ASCs provide cost-effective services and a convenient environment that is less stressful than what many hospitals can offer.
The market's largest segment by application is the segment Hospitals, with a market share of 74.06%in 2022.
The Intraosseous Infusion Devices market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Intraosseous Infusion Devices market covered in Chapter 4:
Biopsybell
Teleflex
BD
Cook Medical
PerSys Medical
SAM Medical
In Chapter 12 and Chapter 14.1, on the basis of types, the Intraosseous Infusion Devices market from 2018 to 2028 is primarily split into:
Manual
Automatic
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Intraosseous Infusion Devices market from 2018 to 2028 covers:
Hospitals
Ambulatory Surgical Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Intraosseous Infusion Devices market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Intraosseous Infusion Devices market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Intraosseous Infusion Devices industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Intraosseous Infusion Devices industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Intraosseous Infusion Devices market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Intraosseous Infusion Devices market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Intraosseous Infusion Devices market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Intraosseous Infusion Devices market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Intraosseous Infusion Devices are medical devices that help infuse drugs, fluids or blood products directly into the bone marrow, for emergency situations. Intraosseous Infusion Devices offer the fastest way to quickly infuse needed medications and fluids in emergency situations.
Market Drivers Analysis
Application of Intraosseous Infusion Devices in First Aid
In the emergency process, the establishment of a fast and effective infusion channel is the prerequisite for ensuring emergency medication. The key to successful rescue is to quickly establish infusion channels for critically ill patients in the emergency department and to quickly infuse fluids with medication. However, unforeseen problems are often encountered during first aid, such as: peripheral circulatory failure in a state of shock, venous collapse, or patient agitation that does not cooperate with the operation; ambulance bumps on the way, making the operation difficult; the scene is complicated and dangerous, or other conditions are limited etc., often delay the rescue time because of the inability to quickly establish an intravenous infusion channel. Bone marrow infusion is easy to identify because of the bone landmarks, and it can be operated in various postures and poor environmental conditions, with a high success rate. For example, emergency surgical critical illness is more common in the emergency department. Taking traffic accidents as an example, the wounded may have craniocerebral injury and chest and abdominal injury at the same time. Complex and critical injuries are often accompanied by shock. Infusion is an important means of anti-shock treatment, but the environment of venipuncture Strict requirements, high requirements for puncture technology, in some special patients such as severe burns, car accidents, explosion wounded, obese patients with edema, shock patients with poor vascular filling, critical patients with sudden cardiac arrest, etc. When there is no available blood vessel, it is difficult to quickly establish a reliable fluid pathway, leaving the healer in a dilemma. In this case, Intraosseous Infusion Devices are the best way to help establish emergency infusion access. In general, the application of Intraosseous Infusion Devices in emergency treatment is one of the driving factors driving the development of the industry.
Challenges Analysis
The popularity of Intraosseous Infusion Devices in some areas is not high
At present, in some areas, the intraosseous cavity infusion technology is still backward, and medical staff do not fully understand the technology and devices. For example, medical staff hold a wait-and-see attitude towards intraosseous infusion technology. The cognition of medical staff on infusion is still at the stage of intravenous administration, and it is difficult to accept the method of intraosseous infusion, and they are worried about the occurrence of complications after infusion, which makes the clinical implementation of intraosseous infusion not smooth. In addition, in terms of medical education, medical students have not learned the knowledge of intraosseous infusion during school, and most hospitals have no relevant training on intraosseous infusion. Still skeptical about the effect of intraosseous infusion, not even using the concept of Intraosseous Infusion Devices. These reasons lead to the low penetration rate of Intraosseous Infusion Devices in critically ill patients, less clinical use, and slower development. In most areas, the original manual bone puncture needle is used for bone puncture. Generally speaking, the low popularity of Intraosseous Infusion Devices in some areas is one of the important factors restricting the development of the industry.
Region Overview:
In 2022, the share of the Intraosseous Infusion Devices market in United States stood at 50.19% .
Company Overview:
Teleflex is a global medical technology provider that improves people's health and quality of life. The company's diverse product portfolio offers solutions in the areas of vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care. The company's brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®, among others. 2020, Teleflex Incorporated has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases.
BD is one of the world's largest global medical technology companies, advancing a healthy world by improving medical discovery, diagnosis and care delivery. The company supports healthcare frontline heroes by developing innovative technologies, services and solutions that help advance clinical care for patients and clinical processes for healthcare providers. On June 22, 2022, BD announced a voluntary recall of the BD™ Intraosseous Needle Set, BD™ Intraosseous Manual Driver Set and BD™ Intraosseous Power Driver.
Teleflex is one of the major players operating in the Intraosseous Infusion Devices market, holding a share of 54.56% in 2023.
Segmentation Overview:
Manual
Differentiate according to the driving mode. Manual devices require the provider to twist the device by hand to pierce the skin, tissue, and bone for access to the bone marrow.
Automatic
Automatic devices include semi-automatic and automatic. This type of product is easy to operate and easy to puncture. Some products of this type are powered by batteries, and common brands on the market include FAST, BIG, etc.
By type, Manual segment accounted for the largest share of market in 2022.
Application Overview:
Mainly divide Hospitals and Ambulatory Surgical Centers according to different downstream institutions. In contrast to Hospitals, Ambulatory Surgical Centers focuses on providing same-day surgical care, including diagnostic and preventive procedures. Ambulatory surgery centers provide surgery without an overnight stay. ASCs provide cost-effective services and a convenient environment that is less stressful than what many hospitals can offer.
The market's largest segment by application is the segment Hospitals, with a market share of 74.06%in 2022.
The Intraosseous Infusion Devices market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Intraosseous Infusion Devices market covered in Chapter 4:
Biopsybell
Teleflex
BD
Cook Medical
PerSys Medical
SAM Medical
In Chapter 12 and Chapter 14.1, on the basis of types, the Intraosseous Infusion Devices market from 2018 to 2028 is primarily split into:
Manual
Automatic
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Intraosseous Infusion Devices market from 2018 to 2028 covers:
Hospitals
Ambulatory Surgical Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Intraosseous Infusion Devices market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Intraosseous Infusion Devices market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Intraosseous Infusion Devices industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Intraosseous Infusion Devices industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Intraosseous Infusion Devices market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Intraosseous Infusion Devices market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Intraosseous Infusion Devices market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Intraosseous Infusion Devices market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
